ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 588,98
-0,27%
Dow Jones
39 127,80
0,04%
DAX
18 166,79
0,02%
Brent Oil
84,905
0,51%
Bitcoin
60 785,58
-0,04%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Terns Pharmaceuticals Inc (TERN)

  7. Terns Pharmaceuticals Inc (TERN) Actualités

TERN

Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TERN
DateHeureSourceTitreSymboleSociété
22/06/202400h30GlobeNewswire Inc.Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference ParticipationNASDAQ:TERNTerns Pharmaceuticals Inc
15/06/202400h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
12/06/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TERNTerns Pharmaceuticals Inc
03/06/202422h10GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
30/05/202414h05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming June Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
17/05/202422h05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics DayNASDAQ:TERNTerns Pharmaceuticals Inc
13/05/202422h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TERNTerns Pharmaceuticals Inc
13/05/202414h05GlobeNewswire Inc.Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
08/05/202422h05GlobeNewswire Inc.Terns Pharmaceuticals Announces Leadership ChangesNASDAQ:TERNTerns Pharmaceuticals Inc
07/05/202422h05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024NASDAQ:TERNTerns Pharmaceuticals Inc
03/05/202422h05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
29/04/202422h05GlobeNewswire Inc.Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive DifferentiationNASDAQ:TERNTerns Pharmaceuticals Inc
10/04/202422h05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
14/03/202421h05GlobeNewswire Inc.Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
11/03/202421h05GlobeNewswire Inc.Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid LeukemiaNASDAQ:TERNTerns Pharmaceuticals Inc
27/02/202422h05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming March Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
16/02/202400h02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
14/02/202414h57Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TERNTerns Pharmaceuticals Inc
07/02/202422h05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
07/02/202414h05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
04/01/202422h05GlobeNewswire Inc.Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TERNTerns Pharmaceuticals Inc
29/11/202322h05GlobeNewswire Inc.Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology SummitNASDAQ:TERNTerns Pharmaceuticals Inc
27/11/202322h05GlobeNewswire Inc.Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
14/11/202314h05GlobeNewswire Inc.Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
13/11/202314h05GlobeNewswire Inc.Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023NASDAQ:TERNTerns Pharmaceuticals Inc
09/11/202314h05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming November Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
02/11/202321h05GlobeNewswire Inc.Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral GLP-1 Receptor Agonist for Treatment of ObesityNASDAQ:TERNTerns Pharmaceuticals Inc
19/10/202322h05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
16/10/202314h05GlobeNewswire Inc.Terns Pharmaceuticals Announces Global Phase 1 Clinical Trial Design of TERN-701 for the Treatment of Chronic Myeloid LeukemiaNASDAQ:TERNTerns Pharmaceuticals Inc
05/09/202322h05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming September Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TERN

Dernières Valeurs Consultées

EU
BN
Danone
EU
DG
Vinci
USI
USTECH100
US Tech 100
EU
MC
Lvmh Moet Hennessy Louis...
EU
BNP
BNP Paribas
FTSE
UKX
FTSE 100
EU
LR
Legrand
NASDAQ
AMZN
Amazon.com
EU
ML
Michelin
EU
VIV
Vivendi
NASDAQ
NVDA
NVIDIA
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés